Newsletter No. 352, December 21

4 de April de 2024
Read more →

IDIVAL and the Optics Group of the University of Cantabria collaborate to advance in glioblastoma surgery through the use of light

21 de March de 2024

The work will allow the development of an optical sensor for the precise identification of tumour margins. Researchers from the Cell Signalling and Therapeutic Targets in Cancer Group of the Valdecilla Research Institute (IDIVAL) and the Optics Group of the University of Cantabria (UC) are collaborating in the development of an optical sensor to aid […]

Read more →

IDIVAL and HUMV organize a course on Generative Artificial Intelligence in basic and/or clinical research

4 de March de 2024

Registrations are open for the seminar that will delve into the types, uses and ethical issues of generative artificial intelligence. Next Monday March 11 will be held the training course called ‘How to improve your workflows with generative AI in basic and/or clinical research’ which will take place in the afternoon (16h to 20h) in […]

Read more →

The Group of Neurodegenerative Diseases at IDIVAL reveals factors that may influence early diagnosis of Alzheimer’s disease

8 de February de 2024

Previous hypertension, diabetes and renal insufficiency could alter plasma markers A multidisciplinary research team belonging to the Neurodegenerative Diseases Group of IDIVAL and the Cognitive Impairment Unit of the Neurology Service of the Marqués de Valdecilla University Hospital (HUMV) has conducted a study aimed at understanding how different physiological variables and previous diseases could influence […]

Read more →

Newsletter nº 322, 18th May

19 de May de 2023
Read more →

Newsletter nº 318, 20t April

28 de April de 2023
Read more →